DiaMed Holding AG

Name

DiaMed Holding AG

Legal name

Bio-Rad Laboratories, Inc.

Website

https://diamed.ch

Company type

Public

Founded year

1977

Operating status

Operating

Short description

DiaMed Holding AG, founded in 1977 in Cressier, Switzerland, develops, manufactures, and markets reagents and instruments for blood typing and antibody screening, serving immunohematology laboratories, blood banks, and hospital blood centers globally.

Ownership category

akta.pro rank

Product category

Immunohematology Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

akta.pro secondary industries

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN), IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

Keywords

• Immunohematology reagents
• Blood typing instruments
• Antibody screening
• Transfusion diagnostics
• Laboratory automation

Headquarters

HQ city

Cressier

HQ country

Switzerland

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels4 records

Marketing channels7 records

Core offering

DiaMed develops, manufactures, and markets a complete line of reagents and instruments used in blood typing and screening, including gel and tube testing reagents, automated instruments (centrifuges, incubators, barcoding systems), and connectivity solutions (IH-Com, IH-Web, IH-AbID) for laboratory information system integration. The company also provides customer support through the BRiCare platform and an integrated IH-Complete workflow offering combining reagents, automation, connectivity, and quality control for immunohematology laboratories, blood banks, and hospital transfusion services.

Differentiator

Problem solved

Functional benefit

Brands

• IH-Com: Connectivity platform for immunohematology lab operations
• IH-Web
• IH-AᵇID
• BRiCare
• IH-Complete

Products and services

• Immunohematology Reagents (Gel and Tube Testing) Card-based and tube-based reagents used by immunohematology laboratories, blood banks, and hospital blood centers for blood typing, antibody detection, and antibody identification in transfusion medicine workflows.
• Automation Instruments Automated instruments (centrifuges, incubators, barcoding systems) for immunohematology testing workflows in clinical laboratories and blood banks.
• IH-Com Connectivity Solution Connectivity platform for immunohematology lab operations that integrates immunohematology instruments with laboratory information systems (LIS).
• IH-Web Connectivity Platform Web-based connectivity platform enabling immunohematology laboratories and blood banks to access and manage testing data.
• IH-AbID Antibody Identification Connectivity Connectivity solution focused on antibody identification workflows, linking instruments and laboratory information systems for immunohematology testing.
• BRiCare Customer Support Platform Customer support platform providing registered laboratory and blood bank customers with technical support, account management, and resources for immunohematology products.
• IH-Complete Workflow Solution Integrated workflow solution that bundles reagents, automation instruments, LIS connectivity, and quality control under a single partner relationship for immunohematology laboratories and blood banks.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered minor.

• Credit Card Processing CompaniesminorOthersThird-party credit card companies used to process online purchases. Credit card numbers are encrypted during transmission for security.
• Third-party Shipping CompaniesminorOthersShipping partners used to fulfill and deliver product orders to customers, including print catalogs and literature.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers is a broad diagnostics incumbent offering hematology and clinical chemistry analyzers used by hospital laboratories. While not a dedicated immunohematology player, it competes for integrated lab wallet share at hospitals that also purchase DiaMed's blood bank products.
• Becton Dickinson (BD): Becton Dickinson's BD Biosciences and Diagnostic Systems segments supply flow cytometry, molecular, and pre-analytical products to clinical and research labs. BD competes with parts of DiaMed's portfolio in clinical research and adjacent blood-based testing workflows.
• Thermo Fisher Scientific: Thermo Fisher Scientific is a broad life sciences and diagnostics incumbent offering immunoassays, specialty diagnostics, and laboratory instruments. It overlaps with DiaMed through its diagnostics portfolio and competes for hospital, blood bank, and reference lab procurement relationships globally.
• Bio-Rad Laboratories: Bio-Rad Laboratories is the publicly traded parent (NYSE:BIO) and a broader life science and clinical diagnostics incumbent. DiaMed operates within Bio-Rad's Immunohematology division alongside Bio-Rad's wider Quality Controls and Life Science portfolios, making Bio-Rad both parent and broad incumbent peer.
• Beckman Coulter (Danaher): Beckman Coulter, part of Danaher, provides hematology analyzers and broader clinical lab solutions to hospitals and reference labs. While not a core immunohematology competitor, it competes for lab automation budgets that overlap with DiaMed's hospital and blood bank installations.
• Abbott Diagnostics: Abbott Diagnostics is a broad diagnostics incumbent with immunoassay, hematology, and blood screening assays used by hospitals and reference labs. Its scale and integrated lab menu overlap with DiaMed's hospital blood center customers and broader IVD procurement decisions.

Direct peers

• Grifols Diagnostic Solutions: Grifols' Diagnostic Solutions division offers blood typing reagents and instruments (e.g., DG Reader, Erytra) for blood banks and donor centers, making it a direct competitor in immunohematology reagent and instrument markets served by DiaMed.
• Immucor (Werfen): Immucor, now part of Werfen, specializes in transfusion and transplant diagnostics with a comparable offering of blood typing reagents, automation instruments (e.g., NEO), and capture-based technology competing head-to-head with DiaMed in immunohematology.
• Ortho Clinical Diagnostics: Ortho Clinical Diagnostics is a leading global provider of immunohematology reagents and instruments (e.g., Ortho Workstation, ID-Micro Typing System) for blood banks and hospital transfusion services, directly competing with DiaMed's gel and tube testing portfolio.

Emerging players

• Quotient Limited: Quotient is an emerging player focused on transfusion diagnostics, including the MosaiQ platform for blood typing and serological disease screening. It competes with DiaMed in next-generation immunohematology workflows and represents an emerging technology overlap.

Market position

Customer concentration

• Xx.com/biorad_diagsolu

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DiaMed Holding AG